Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00568126 · ClinicalTrials.gov registry record · Phase 3
Study of Maca Root for the Treatment of Antidepressant-Induced Sexual Dysfunction in Females
A Phase 3 study of Antidepressant Induced Sexual Dysfunction, sponsored by Massachusetts General Hospital.
- Completed
- Registry status
- Phase 3
- Development phase
- 45
- Enrollment target
- 1
- Study location
NCT00568126 is a Phase 3 study of Antidepressant Induced Sexual Dysfunction that has completed, run by Massachusetts General Hospital. The registered enrollment target is 45 participants. The trial reports 1 study location across 1 state.
The verdict
NCT00568126, a Phase 3 study of Antidepressant Induced Sexual Dysfunction, has completed, sponsored by Massachusetts General Hospital.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 45 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to find out whether Maca Root is effective for treating sexual dysfunction in females that is caused by antidepressant drugs. An additional aim of the study is to document the safety and tolerability of maca root, as well as any potential side effects that it causes.
Conditions Studied
Interventions
- DRUG Placebo
- DRUG Maca Root
Study Locations (1)
Massachusetts
- Depression Clinical and Research Program, Massachusetts General Hospital - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 45 participants |
| Start Date | 2007-12-27 |
| Est. Completion | 2010-10-05 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00568126
The ClinicalTrials.gov registry entry for NCT00568126 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 45 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Antidepressant Induced Sexual Dysfunction appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.
NCT00568126 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.
Frequently Asked Questions
What is clinical trial NCT00568126 about?
NCT00568126 is a clinical study titled "Study of Maca Root for the Treatment of Antidepressant-Induced Sexual Dysfunction in Females". The purpose of this study is to find out whether Maca Root is effective for treating sexual dysfunction in females that is caused by antidepressant drugs. An additional aim of the study is to document the safety and tolerability of maca root, as well as any potential side effects that it causes.
What is the current status of trial NCT00568126?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 45 participants. The study started on 2007-12-27. Estimated completion is 2010-10-05.
What conditions does trial NCT00568126 study?
This clinical trial studies the following conditions: Antidepressant Induced Sexual Dysfunction.
What interventions are being tested in trial NCT00568126?
The interventions under investigation include: Placebo (DRUG), Maca Root (DRUG).
Who is sponsoring clinical trial NCT00568126?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00568126 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.